Discontinuities and senior management: assessing the role of recognition in pharmaceutical firm response to biotechnology

Sarah Kaplan, Fiona Murray and Rebecca Henderson

Industrial and Corporate Change, 2003, vol. 12, issue 2, 203-233

Abstract: Despite an increasing emphasis on the role of senior management cognition in shaping organizational action, there have been few attempts to link top management mental models to strategic choice in the face of discontinuous innovation. This paper uses 23 years of data covering 15 major pharmaceutical firms to explore the degree to which each firm's response to the revolution in biotechnology was shaped by the senior team's recognition of biotechnology's importance. Controlling for a number of important alternative explanations, we show that recognition may be an important predictor of action, suggesting that cognition at the most senior level can play a critical role in shaping established firms' response to discontinuities. Copyright 2003, Oxford University Press.

Date: 2003
References: Add references at CitEc
Citations: View citations in EconPapers (70)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:indcch:v:12:y:2003:i:2:p:203-233

Ordering information: This journal article can be ordered from
https://academic.oup.com/journals

Access Statistics for this article

Industrial and Corporate Change is currently edited by Josef Chytry

More articles in Industrial and Corporate Change from Oxford University Press and the Associazione ICC Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().